Aquilo Capital Management, LLC Magenta Therapeutics, Inc. Transaction History

Aquilo Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $8.05 Million - $16.5 Million	-3,155,082 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $2.84 Million - $4.63 Million	467,899 Added 17.41%	3,155,082 $23 Million
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $1.81 Million - $2.62 Million	184,973 Added 7.39%	2,687,183 $26.3 Million
Q1 2021 May 17, 2021	BUY	$7.66 - $13.38 $1.81 Million - $3.15 Million	235,787 Added 10.4%	2,502,210 $29.6 Million
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $7.98 Million - $10.4 Million	1,307,805 Added 136.43%	2,266,423 $17.8 Million
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $6.25 Million - $8.57 Million	958,618 New	958,618 $6.52 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.